LATEST

River Card and Cloud Forest clash at Newbury●Wolff 'not at all' disappointed by Verstappen's new Red Bull deal●Mayer: I feel unbeatable - Cameron fight won't be close!●Second man held over fatal Fagersta school attack●PODCAST 🎧: Food prices and strikes - How the hellish summer has hit life in France●Google Cloud has launched Gemini Enterprise for Legal with Freshfields, Cleary and Weil●Higher education: Renting a room in Lisbon costs over €500 as demand outstrips supply●US robotaxi firm Waymo plans to launch in Munich● River Card and Cloud Forest clash at Newbury●Wolff 'not at all' disappointed by Verstappen's new Red Bull deal●Mayer: I feel unbeatable - Cameron fight won't be close!●Second man held over fatal Fagersta school attack●PODCAST 🎧: Food prices and strikes - How the hellish summer has hit life in France●Google Cloud has launched Gemini Enterprise for Legal with Freshfields, Cleary and Weil●Higher education: Renting a room in Lisbon costs over €500 as demand outstrips supply●US robotaxi firm Waymo plans to launch in Munich●

Longevity

AlzeCure banks $10m as Lilly deal closes

Longevity.Technology 25 August 2026, 12:01 UTC 19h ago

AlzeCure banks $10m as Lilly deal closes — Longevity.Technology

AlzeCure collects its upfront payment from Eli Lilly for Alzheimer’s candidate ACD680, with a deal that could top $1 billion still in play. Ten million dollars landed in AlzeCure Pharma’s account this week. It’s not a huge number by pharma standards, but it’s the opening move in a deal that could eventually be worth more […] The post AlzeCure banks $10m as Lilly deal closes appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.

Read full coverage at Longevity.Technology →

More from Longevity

Mount Sinai’s $1m XPRIZE bet: reset immune system, slow aging

Longevity.Technology · 15h ago

CND Life Sciences funding backs earlier Parkinson’s detection

Longevity.Technology · 15h ago

Denali Therapeutics’ brain-crossing drug hits market

Longevity.Technology · 16h ago

Shingles vaccine linked to 24% lower dementia risk

Healthy Aging News -- ScienceDaily · 18h ago

Study Links Varied Diet in Older Adults to Lower Anxiety, Better Cognitive Function

Naturalnews.com · 1d ago

A Tougher Extracellular Matrix Strengthens Tendons in Rats

Lifespan Research Institute · 1d ago